Valeant CEO says he, company were 'too aggressive' in boosting drug prices
Valeant Pharmaceutical's soon-to-be-former CEO, J. Michael Pearson, is to tell U.S. Senate committee that he and the company were 'too aggressive' in bumping up prices on some of its drug products.
from CBC | Health News http://ift.tt/1NTBtmV
ABOUT THE AUTHOR
Hello We are OddThemes, Our name came from the fact that we are UNIQUE. We specialize in designing premium looking fully customizable highly responsive blogger templates. We at OddThemes do carry a philosophy that: Nothing Is Impossible
0 commentaires:
Enregistrer un commentaire